Legal Opinion

In re Testosterone Replacement Therapy Products Liability Litigation Coordinated Pretrial Proceedings

District Court, N.D. Illinois

Decided November 9, 2015No. 14 C 1748; MDL No. 2545PublishedCited by 3 opinions

1Opinion of the Court

MEMORANDUM OPINION AND ORDER

MATTHEW F. KENNELLY, United States District Judge

This multidistrict litigation proceeding (MDL) involves lawsuits by over 2,500 plaintiffs who allege that they have suffered injuries caused by defendants’ testosterone replacement therapy (TRT) drugs. The Judicial Panel on Multidistrict Litigation consolidated the cases before this Court for pretrial proceedings. Eight defendants— Actavis, Inc., Actavis Phar-ma, Inc., Actavis Laboratories UT, Inc., Watson, Laboratories, Inc. (the Actavis de*748fendants); Pfizer Inc. and Pharmacia & Upjohn Company, LLC (the Pfizer…

2Cases cited9 opinions

  1. Wyeth v. LevineSupreme Court of the United States · 2009
  2. PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
  3. Yanise Germain v. Teva Pharmaceuticals, USA, IncCourt of Appeals for the Sixth Circuit · 2014
  4. Mutual Pharmaceutical Co. v. BartlettSupreme Court of the United States · 2013
  5. Morris v. PLIVA, Inc.Court of Appeals for the Fifth Circuit · 2013

4 more not listed; retrieve them via the Exa API.

3Cited by3 opinions

  1. Rodney Guilbeau v. Pfizer Inc.Court of Appeals for the Seventh Circuit · 2018
  2. Greager v. McNeil PPC, Inc.District Court, N.D. Illinois · 2019
  3. Vriner v. Teva Pharmaceuticals USA, Inc.District Court, N.D. Illinois · 2021

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API